DEMENTIA IN DISTRESS: CHALLENGES WHEN CONSIDERING PSYCHOTROPIC MEDICATIONS FOR NEUROPSYCHIATRIC SYMPTOMS

Symposia

  • Date:
  • Time: 2:45pm - 3:45pm
  • Track: Clinical Practice
  • Location: N. Hemisphere B-E
  • CME/CE: 1.0 - AMA Credits, AAFP Prescribed Credits, AOA Category 2-A Credits, AMDA Clinical Credits, Nursing Credits, Pharmacy Credits

Sponsored by the Ethnogeriatrics Committee and the Interprofessional Education/Practice Special Interest Group
Moderator: Joseph O. Nnodim, MD, PhD, AGSF, FACP

Learning Objectives: (1) recognize the challenges of using psychotropic medications for the management of neuropsychiatric distress in dementia in the absence of stringent clinical guidelines and FDA-approved treatments; (2) determine the indications for prescribing psychotropic agents when all non-pharmacological approaches have failed and utilize practical guidelines on how to dose these medications and monitor their efficacy; (3) recognize serious risks and complications related to psychotropic medications when used to manage neuropsychiatric symptoms of dementia, and compare and contrast the availability and cost of commonly used psychotropic medications; (4) recognize some of the different cultural notions, including myths about dementia, that can affect provider, patient, and caregiver interactions when discussing diagnoses, causation, treatment; and (5) determine how cultural differences and language barriers and limited health literacy can impact the care of patients with dementia exhibiting neuropsychiatric distress and their families.

Psychotropic Medications in Treatment of Neuropsychiatric Symptoms Related to Dementia: Pros and Cons
Grace C. Nadolny, MD & Mehrdad Ayati, MD
Complications and Costs of Psychotropic Medications for Management of Neuropsychiatric Symptoms of Dementia
Grace C. Nadolny, MD & Mehrdad Ayati, MD
Cultural and Ethnical Implications when Treating Neuropsychiatric Distress in Dementia
Ella H. Bowman, MD, PhD, AGSF, FAAHPM